# Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure.

> **NCT05392673** · NA · COMPLETED · sponsor: **Xiangya Hospital of Central South University** · enrollment: 186 (actual)

## Conditions studied

- Chronic-on-acute Liver Failure

## Interventions

- **OTHER:** KM-8800 plasma exchange device (Kuraray, Tokyo, Japan)

## Key facts

- **NCT ID:** NCT05392673
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392673, "Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure.". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT05392673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*